SCHEMBL6329673

SCHEMBL6329673

Cc1nn(-c2ccc3onc(N)c3c2)c2c1CCN(c1ccc(-c3ccccc3CO)cc1)C2=O

nearest known ligand 0.85

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 19/20 0.85
F2 P00734 16/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8359229 0.81 F10 (1.00) F10F2
SCHEMBL8360892 0.78 F10 (1.00) F10F2
SCHEMBL12589588 0.78 F10 (1.00) F10F2
SCHEMBL8360280 0.78 F10 (1.00) F10F2
SCHEMBL14580462 0.78 F10 (0.80) F10F2
SCHEMBL14612522 0.78 F10 (0.89) F10F2
SCHEMBL8355307 0.77 F2 (0.86) F10F2
SCHEMBL8358066 0.76 F10 (0.76) F10F2
SCHEMBL5641570 0.71 F10 (0.69) F10F2
SCHEMBL2003260 0.71 F10 (0.64) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6858616-B2 Nitrogen containing heterobicycles as factor Xa inhibitors BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-02-22 US disclosed